Takatsuki, Japan

Akinobu Higashi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akinobu Higashi: Innovator in Pharmaceutical Chemistry

Introduction

Akinobu Higashi is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as Janus kinase (JAK) inhibitors. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Akinobu Higashi holds 2 patents. His latest patents include processes for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof. These derivatives are particularly useful as JAK inhibitors, which play a crucial role in treating various diseases. The processes he developed also include methods for preparing specific compounds using salts of (3S,4R)-1-benzyl-3-methyl-1,6-diazaspiro[3.4]octane with organic acids.

Career Highlights

Throughout his career, Akinobu has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Japan Tobacco Inc. and Leo Pharma A/S. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation and development.

Collaborations

Akinobu has collaborated with several professionals in his field, including Hiromu Takiguchi and Takashi Inaba. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Akinobu Higashi's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of important therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…